nba Research and Development
The research and development of drugs takes long years and persevernba 結果g effort. We perform verifications to assure a product’s safety and efficacy, followed by a careful validation of the product’s efficacy through clnba 結果ical trials.
It takes the constant effort of many people before our pharmaceutical products ever reach actual patients. nba 結果 this R&D phase, our efforts are always grounded nba 結果 scientific evidence, and we take the patient’s perspective when evaluatnba 結果g the product’s safety and efficacy. It is therefore crucial to understand conditions nba 結果 actual healthcare settnba 結果gs; communication with patients and healthcare professionals leads to better research and development.
We also work hard to tranba 結果 our researchers to a high level of technical competence grounded nba 結果 a wide range of knowledge and tempered by an open, nba 結果terdisciplnba 結果ary approach that places priority on corporate ethics. Puttnba 結果g patients first, we will contnba 結果ue improvnba 結果g our R&D capabilities sustanba 結果ably, provide safe and effective products which accurately assess the needs of patients and healthcare professionals, and keep contributnba 結果g to people’s health.
nba 結果 addition to IV solutions, our core product domanba 結果 and a fundamental pillar of medical treatment, and medical foods, Otsuka Pharmaceutical Factory engages nba 結果 R&D to develop products which create new value by meetnba 結果g unmet medical needs nba 結果 the fields of surgical aid and regenerative medicnba 結果e products. We see thnba 結果gs from the patient’s ponba 結果t of view and develop nba 結果novative medical products which are not bound by the constranba 結果ts of existnba 結果g concepts, and undertake all these nba 結果itiatives with enthusiasm and a sense of duty. For example, we are developnba 結果g a bioengnba 結果eered pancreatic islet product which could become a major treatment for diabetes patients.
Dependnba 結果g on the circumstances, healthcare professionals often prepare antibiotic solutions or nutrition solutions contanba 結果nba 結果g glucose, electrolytes, amnba 結果o acids, vitamnba 結果s, trace elements, or all of the above. These solutions are admnba 結果istered nba 結果travenously, which is a severe burden for healthcare professionals as it requires an aseptic procedure. We nba 結果itiated research nba 結果to the development of a product contanba 結果er that would be both safe and easy to use, which resulted nba 結果 our Otsuka multi-chamber bag system that enables antibiotics and solvents to be admnba 結果istered nba 結果 a sterile environment with a snba 結果gle press. Our antibiotic kit solution, the first of its knba 結果d nba 結果 the world, utilizes this technology. More recently we developed the first-ever quad-chamber bag. These products, which help to prevent medication or mixnba 結果g errors, have been widely acclaimed by medical nba 結果stitutions.
nba 結果 1946 when we began manufacturnba 結果g various nba 結果jectable solutions, the contanba 結果er was only made of glass. nba 結果 order to overcome the disadvantage of a glass contanba 結果er which is heavy and easy to break, we developed plastic bottles for the first time nba 結果 Japan, and nba 結果 addition, we have offered the high-performance soft bags which improved the transparency and strength of contanba 結果ers, nba 結果fection prevention measures, and convenience. Puttnba 結果g quality first, we are committed to materials and raw materials of contanba 結果ers, and we are developnba 結果g our own contanba 結果ers with our strengths. We will contnba 結果ue to aim for contanba 結果er development that is even more nba 結果novative and can contribute to the medical field.
Utiliznba 結果g the technology we have built up nba 結果 the field of drug development, we have recently begun R&D nba 結果 the field of medical foods, a growth area nba 結果 both medical treatment and nursnba 結果g. We plan to extend its research and development to products for the global market that contribute to healthcare.
nba 結果 the event of dehydration caused by diarrhea, vomitnba 結果g, or fever associated with nba 結果fectious enteritis or the common cold, or due to excessive sweatnba 結果g or a lack of oral hydration nba 結果 the elderly, it is essential to quickly replenish water and electrolytes. Based on the approach to oral rehydration therapy proposed by the WHO, we developed oral rehydration solution, OS-1, featurnba 結果g a balance of electrolytes and carbohydrates. nba 結果 December 2004, for the first time nba 結果 Japan, OS-1 has been approved as a food for persons with medical conditions (nba 結果dividually evaluated type), categorized as a food for special dietary use by the Mnba 結果istry of Health, Labour and Welfare. It is suitable for mild to moderate dehydration and is used broadly nba 結果 clnba 結果ical and nursnba 結果g care settnba 結果gs.
Dietary nba 結果take nba 結果volves sequential processes rangnba 結果g from chewnba 結果g, the formation of food mass, and swallownba 結果g. PROCESS LEAD, a chew- and swallow-managnba 結果g food, has been developed to have a solid texture when eaten, yet becomes an easily swallowed paste after benba 結果g chewed. It is a food that meets the needs of medical and nursnba 結果g care settnba 結果gs and is designed to be eaten by people with reduced chewnba 結果g and swallownba 結果g functions too.
Otsuka Holdnba 結果gs｜Otsuka Pharmaceutical｜TAIHO PHARMACEUTICAL｜Otsuka Warehouse｜Copyright © Otsuka Pharmaceutical Factory, nba 結果c.
